XML 48 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Schedule of fair values of derivative instruments

   Active
Market
for Identical
Assets
(Level 1)		   Observable
Inputs
(Level 2)		   Unobservable
Inputs
(Level 3)		   Total
Carrying
Value		 
Cash and cash equivalents and restricted cash   23,894,370    -   $-    23,894,370 
Financial assets available for sale   -    -    159,946    159,946 
Notes payable   -    21,758,227    -    21,758,227 
Financial liability   -    -    71,757    71,757 
Warrants liability   -    120,000   $-    120,000 
                     
Total   23,894,370    21,878,227   $231,703    46,004,300 

 
Schedule of revenue by major source in each segment
For the three months ended December 31  2019   2018 
Retail drugstores
Prescription drugs  $7,496,469   $6,756,073 
OTC drugs   10,260,883    9,393,148 
Nutritional supplements   1,602,407    1,869,351 
TCM   1,416,126    1,342,768 
Sundry products   188,484    248,729 
Medical devices   611,597    1,257,180 
Total retail revenue  $21,575,966   $20,867,249 
Online pharmacy          
Prescription drugs  $-   $- 
OTC drugs   1,981,871    837,126 
Nutritional supplements   245,249    220,776 
TCM   42,331    28,785 
Sundry products   729,179    573,993 
Medical devices   966,393    832,526 
Total online revenue  $3,965,023   $2,493,206 
Drug wholesale          
Prescription drugs  $6,358,031   $3,933,441 
OTC drugs   1,310,927    3,341,676 
Nutritional supplements   47,736    167,069 
TCM   67,507    77,216 
Sundry products   19,789    5,949 
Medical devices   18,303    30,743 
Total wholesale revenue  $7,822,293   $7,556,094 
Total revenue  $33,363,282   $30,916,549 

 

For the nine months ended December 31  2019   2018 
Retail drugstores
Prescription drugs  $19,214,689   $17,835,700 
OTC drugs   24,964,312    24,018,263 
Nutritional supplements   4,510,514    4,750,013 
TCM   4,474,676    4,615,033 
Sundry products   777,432    799,554 
Medical devices   2,370,604    2,953,326 
Total retail revenue  $56,312,227   $54,971,889 
Online pharmacy          
Prescription drugs  $-   $- 
OTC drugs   4,133,128    2,412,057 
Nutritional supplements   488,956    575,862 
TCM   77,981    54,417 
Sundry products   1,542,372    2,128,282 
Medical devices   2,517,455    1,467,304 
Total online revenue  $8,759,892   $6,637,922 
Drug wholesale          
Prescription drugs  $18,054,557   $11,708,683 
OTC drugs   3,433,730    7,246,356 
Nutritional supplements   104,475    240,666 
TCM   247,465    156,525 
Sundry products   30,809    21,479 
Medical devices   54,690    114,641 
Total wholesale revenue  $21,925,726   $19,488,350 
Total revenue  $86,997,845   $81,098,161 
Schedule of receivables and contract liabilities from contracts with customers

 

   December 31,
2019		   March 31,
2019		 
Trade receivable(included in accounts receivable, net)  $11,465,402   $8,692,514 
Contract liabilities (included in accrued expenses)   1,634,032    1,689,099 
Schedule of cash equivalents and restricted cash

 

   December 31,
2019		   March 31,
2019		 
Cash and cash equivalents  $11,858,985   $9,322,463 
Restricted cash   12,035,385    15,422,739 
Cash, cash equivalents and restricted cash  $23,894,370   $24,745,202 
Schedule of estimated useful lives of property and equipment

    Estimated
Useful Life
Leasehold improvements   3-10 years
Motor vehicles   3-5 years
Office equipment & furniture   3-5 years
Buildings   35 years
Schedule of estimated useful lives of intangible assets

    Estimated
Useful Life
Land use rights   50 years
Software   3 years
Schedule of condensed consolidated balance sheet

 

   Impact of Change in Accounting Policy 
   As Reported       Adjusted 
   March 31,
2019		   Adjustments   April 1,
2019		 
Other current assets   2,063,375    (717,414)   1,345,961 
Total current assets   56,202,981    (717,414)   55,485,567 
Operating lease right-of-use assets   -    15,276,388    15,276,388 
Total assets   72,730,636    14,558,974    87,289,610 
                
Current portion of operating lease liabilities   -    4,718,610    4,718,610 
Total current liabilities   55,212,286    4,718,610    59,930,896 
Long-term operating lease liabilities   -    9,418,011    9,418,011 
Total liabilities   55,759,469    14,136,621    69,896,090 
                
Retained earnings   (30,587,468)   422,354    (30,165,114)
Total shareholders' equity   18,165,206    422,354    18,587,560 
Total  equity   16,971,167    422,354    17,393,521